echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > European Radiology: Prediction of preoperative T stage of rectal cancer by a 3D super-resolution MRI radiomics model based on deep learning

    European Radiology: Prediction of preoperative T stage of rectal cancer by a 3D super-resolution MRI radiomics model based on deep learning

    • Last Update: 2022-10-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Currently, colorectal cancer ranks third and second
    in the global spectrum of tumor incidence and death, respectively.
    Rectal cancer (RC) accounts for 1/3 of colorectal cancers and has the highest
    incidence in East Asia.
    Although radical surgery remains the only cure, the implementation of neoadjuvant chemotherapy (nCRT) based on pre-treatment staging has increased the rate of R0 resection and further improved local tumor control
    .
    nCRT is recommended as standard of care for patients with locally advanced RC (LARC) (T3/4 and/or N+), while there is no indication for treatment in patients with early stage (T1/2 and N-
    ).
    To avoid overtreatment or undertreatment, accurate preoperative assessment of the T stage to distinguish between T1/2 and T3/4 tumors is essential
    .
    High-resolution (HR) T2-weighted imaging (T2WI) has fine soft tissue resolution and has become the first-line imaging method of RC office in partial stages.
    However, overall accuracy ranged from 60 to 75%, with studies reporting an average overstaging rate of 30-57%
    for T2 tumors.
    In this case, improving the evaluation of the T stage of the primary tumor has important clinical value
    for precise treatment and optimization of treatment strategies.

    As an emerging data extraction method, radiomics can quantitatively assess tumor heterogeneity
    by mining high-dimensional data in medical images.
    Studies have shown that radiomics can improve patient management and clinical decision-making
    by discovering disease features invisible to the human eye.
    In RC, radiomics has performed impressively in different oncology scenarios, including assessing the biological behavior of tumors, assessing response to treatment, and predicting prognosis
    .
    Despite these advances, radiomic features are often influenced
    by anisotropic resolution and low voxel statistics in current medical imaging.
    In order to improve the robustness and stability of radiomics models, it is quite important
    to address these limitations by applying higher resolution images in model construction.

    Super-resolution (SR) technology, which aims to recover higher spatial resolution of digital images from low-resolution observations, has been proposed and introduced into the clinic since the 80s of the
    20th century.
    In recent years, with the development of deep learning (DL), SR has achieved excellent performance
    in medical imaging.
    In addition to the recovered SR images showing good stability and reliability in multispatial trapezoids, DL-SR has also attracted attention in medical imaging, as radiomic features extracted from SR images have been quantitatively demonstrated to have obvious repeatability and stability
    .
    However, none of the current radiomics studies have utilized DL-SR technology to discover specific radiogramic biomarkers for clinical use
    .

    Recently, a study published in the journal European Radiology developed and validated an SR radiomics model for preoperative prediction of T stage in RC patients, the first DL-based three-dimensional (3D) SR radiomics study
    to be demonstrated in the clinic.

    A total of 76 eligible RC patients (T1/2=287, T3/4=419) were included and allocated chronologically as training cohorts (n=565) and validation cohorts (n=141).

    In this study, a deep transfer learning network analysis was performed on high-resolution (HR) T2-weighted imaging (T2WI) to improve the Z-resolution of images, and preoperative SRT2WI was obtained
    .
    The radiomics models named modelHRT2 and modelSRT2 were constructed
    from high-dimensional quantitative features extracted by the minimum absolute contraction and selection combinator methods in artificially segmented volumes of interest of HRT2WI and SRT2WI, respectively.
    The performance of the model is evaluated
    by ROC, calibration, and decision curves.

    ModelSRT2 was superior to modelHRT2 in differentiating T1/2 from T3/4 RC (AUC 0.
    869, sensitivity 71.
    1%, specificity 93.
    1%, accuracy 83.
    3% and AUC 0.
    810, sensitivity 89.
    5%, specificity 70.
    1%, accuracy 77.
    3%), the difference was significant (P < 0.
    05).

    Both radiological models achieved higher AUCs than radiologists (0.
    685, 95% confidence interval 0.
    595-0.
    775, P < 0.
    05).

    The calibration curve confirmed the high fit, and the decision curve analysis confirmed its clinical value
    .


    Graph model evaluation
    .
    Cumulative distribution curve
    of A Rad scores.
    ROCs
    for training (B) and testing (C) cohorts.
    The calibration curve shows a good calibration of the model in both cohorts (D-G)

    This study proposes a DL-based three-dimensional SR radiomics model that outperforms traditional HRT2 radiomics models and radiologists
    in predicting tumor T staging and identifying nCRT candidates in RC patients.
    This is the first time so far that DL-based 3D SR methods have been applied to radiomic analysis
    for clinical decision support.
    With further validation, the clinical utility of radiomics through SR imaging will be maximized
    .

    Original source:

    Min Hou,Long Zhou,Jihong Sun.
    Deep-learning-based 3D super-resolution MRI radiomics model: superior predictive performance in preoperative T-staging of rectal cancer.
    DOI:10.
    1007/s00330-022-08952-8

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.